Synonyms: GB-0139 | GB0139 | TD-139 | TD139
Compound class:
Synthetic organic
Comment: Olitigaltin (GB0139) is a galectin-3 inhibitor [3] that is designed for inhalation, and is intended as a therapy for fibrotic lung conditions such as idiopathic pulmonary fibrosis (IPF) [1]. In the fibrotic setting, blocking galectin-3's biological function is predicted to combat the enhanced TGF-β receptor-mediated macrophage differentiation and myofibroblast activation that drives pathological fibrotic changes [2-4].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
International Nonproprietary Names ![]() |
|
INN number | INN |
12032 | olitigaltin |
Synonyms ![]() |
GB-0139 | GB0139 | TD-139 | TD139 |
Database Links ![]() |
|
CAS Registry No. | 1450824-22-2 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297442 |
DrugBank Ligand | DB12895 |
GtoPdb PubChem SID | 472319270 |
PubChem CID | 73774610 |
RCSB PDB Ligand | TD2, TD2 |
Search Google for chemical match using the InChIKey | YGIDGBAHDZEYMT-MQFIMZJJSA-N |
Search Google for chemicals with the same backbone | YGIDGBAHDZEYMT |
Search PubMed clinical trials | olitigaltin |
Search PubMed titles | olitigaltin |
Search PubMed titles/abstracts | olitigaltin |
UniChem Compound Search for chemical match using the InChIKey | YGIDGBAHDZEYMT-MQFIMZJJSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YGIDGBAHDZEYMT-MQFIMZJJSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Olitigaltin (links to external site)
Cat. No. HY-19940 |